CytoSorbents

CytoSorbents (OTCBB:CTSO) is a publicly-traded medical device company who has developed CytoSorb, a patented technology designed to treat potentially fatal “cytokine storm”, aka sepsis.

Phillip Chan, MD, CEO
7 Deer Park Drive, Suite K
Monmouth Junction, NJ 08852
Tel: 732-329-8885
Fax: 732-329-8650